{
    "clinical_study": {
        "@rank": "147857", 
        "acronym": "CogEcig", 
        "arm_group": [
            {
                "arm_group_label": "Own Brand cigarette", 
                "arm_group_type": "Active Comparator", 
                "description": "Smoke Own Brand cigarette, 15 puff of cigarette."
            }, 
            {
                "arm_group_label": "One High 2,4% nicotine", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette."
            }, 
            {
                "arm_group_label": "Original 7,4 mg nicotine", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette Original 7,4 mg nicotine for a day. 15 puff of e-cigarette."
            }, 
            {
                "arm_group_label": "Nicotine Free", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Smoke electronic cigarette nicotine free (15 puff)"
            }, 
            {
                "arm_group_label": "EGO 9mg", 
                "arm_group_type": "Experimental", 
                "description": "Smoke electronic cigarette EGO for a day (15 puff)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to compare cognitive scores (attention, executive function\n      and working memory) of  different e-Cigarette strength with usual cigarettes."
        }, 
        "brief_title": "CogEcig: Cognitive Functioning and Electronic Cigarette", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Tobacco Abuse Smoke", 
        "condition_browse": {
            "mesh_term": "Tobacco Use Disorder"
        }, 
        "detailed_description": {
            "textblock": "The study is randomised cross-over trial designed to compare: 1) Cognitive performances\n      levels for four different e-Cigarette strength. Participants will be  requested to abstain\n      from smoking and alcohol from 20:00 on the night before each study day and from food and\n      caffeine for at least 1 h before the session. On arrival at the study centre, carbon\n      monoxide (CO) will be measured in participants' expired breath. If CO will be >15 parts per\n      million (ppm), the assigned study treatment will be allocated; however, if CO was >15 ppm or\n      they will report smoking in the previous 12 h, participants will be rescheduled wherever\n      possible to a subsequent session.\n\n      On the first study day, participants will be  randomised to use one of five ordered\n      conditions: Electronic Nicotine Delivery Device (ENDD) (fourth generation) containing\n      nicotine 2,4%; Electronic Nicotine Delivery Device (ENDD (second generation) containing\n      nicotine 7,4 mg;  Electronic Nicotine Delivery Device (ENDD containing nicotine 9 mg;\n      Electronic Nicotine Delivery Device (ENDD nicotine free;  their usual cigarette.\n      Additionally participants will be trained to use an electronic cigarette. The following\n      tests will be completed at the each visits: Continuous Performance Test - AX version\n      (CPT-AX), Wisconsin card sorting test( WCST), Working memory test (N-BACK)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 regular smokers (smoking \u2265 15 factory-made cigarettes per day for at least the\n             past 10 years and not currently attempting to quit smoking or wishing to do so in the\n             next 30 days, CO > 10 parts per million ) will be recruited from the local Hospital\n             staff in Catania, Italy.\n\n        Exclusion Criteria:\n\n          -  people who reported recent myocardial infarction, angina pectoris or other serious\n             medical conditions (diabetes mellitus, severe allergies, poorly controlled asthma or\n             other airways disease, poorly controlled psychiatric disorders or current chemical\n             dependence other than nicotine) and\n\n          -  pregnancy,\n\n          -  breastfeeding,\n\n          -  blood pressure > 180 mm Hg systolic and/or 100 mm Hg diastolic,\n\n          -  weight < 45 or > 120 kg, or\n\n          -  current use of any other smoking cessation medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01735487", 
            "org_study_id": "CogEcig"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 15 puff of, Own Brand cigarettes;", 
                "intervention_name": "Own Brand cigarette", 
                "intervention_type": "Other", 
                "other_name": "Own Brand cigarette"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "Original 7,4 mg nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 25 puff, of electronic cigarette one high 2,4% nicotine", 
                "intervention_name": "one high 2,4% nicotine", 
                "intervention_type": "Other", 
                "other_name": "Categoria electronic cigarette one high 2,4% nicotine"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Nicotine Free", 
                    "EGO 9mg"
                ], 
                "description": "Smoke, 15 puff, of Categoria electronic cigarette 7,4 mg nicotine", 
                "intervention_name": "original 7,4 mg nicotine", 
                "intervention_type": "Other", 
                "other_name": "Categoria electronic cigarette 7,4 mg nicotine"
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Original 7,4 mg nicotine", 
                    "EGO 9mg"
                ], 
                "description": "smoke, 15 puff, of electronic cigarette nicotine free", 
                "intervention_name": "nicotine free", 
                "intervention_type": "Other", 
                "other_name": "categoria electronic cigarette nicotine free \"mint\"."
            }, 
            {
                "arm_group_label": [
                    "Own Brand cigarette", 
                    "One High 2,4% nicotine", 
                    "Nicotine Free"
                ], 
                "description": "smoke, 15 puff, of electronic cigarette Ego 9 mg", 
                "intervention_name": "Ego 9mg", 
                "intervention_type": "Other", 
                "other_name": "electronic cigarette Ego 9 mg nicotine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Catania", 
                    "country": "Italy", 
                    "zip": "95124"
                }, 
                "name": "Centro per la Prevenzione e Cura del Tabagimso"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "5", 
        "official_title": "Electronic Cigarette and Cognitive Functioning: (CogEcig)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Compare cognitive performances in subjects who smoke \"Categoria\" electronic cigarettes labelled Original 7,4 mg nicotine , \"Categoria\" electronic cigarettes labelled One 2,4% nicotine, \"Categoria\" electronic cigarettes labelled \"Mint\" nicotine free,  electronic cigarettes labelled Ego 9 mg nicotine  with usual cigarettes.", 
            "measure": "Cognitive Performances", 
            "safety_issue": "No", 
            "time_frame": "35 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01735487"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universita degli Studi di Catania", 
            "investigator_full_name": "Riccardo Polosa", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universita degli Studi di Catania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universita degli Studi di Catania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}